A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP)
Status:
Completed
Trial end date:
2018-11-06
Target enrollment:
Participant gender:
Summary
VinCaP is a multicentre single-arm phase II trial. 22 patients will receive Vinflunine
chemotherapy (Vinflunine 320mg/m2 given intravenously on day 1 of each cycle of 21 days, four
cycles to be given prior to formal re-staging).